David Rescott

Stock Analyst at Baird

(3.17)
# 1,031
Out of 4,650 analysts
44
Total ratings
48.65%
Success rate
2.5%
Average return

Stocks Rated by David Rescott

Edwards Lifesciences
Oct 25, 2024
Maintains: Neutral
Price Target: $73$68
Current: $68.52
Upside: -0.76%
Intuitive Surgical
Oct 18, 2024
Maintains: Outperform
Price Target: $503$565
Current: $510.88
Upside: +10.59%
LivaNova
Sep 17, 2024
Upgrades: Outperform
Price Target: $55$66
Current: $53.16
Upside: +24.15%
Medtronic
Aug 21, 2024
Maintains: Neutral
Price Target: $82$90
Current: $90.60
Upside: -0.66%
Penumbra
Jul 31, 2024
Maintains: Outperform
Price Target: $231$180
Current: $208.74
Upside: -13.77%
Inari Medical
Jul 31, 2024
Maintains: Outperform
Price Target: $65$63
Current: $42.56
Upside: +48.03%
Boston Scientific
Jul 25, 2024
Maintains: Outperform
Price Target: $90$91
Current: $84.76
Upside: +7.36%
Merit Medical Systems
Jun 28, 2024
Initiates: Outperform
Price Target: $96
Current: $95.31
Upside: +0.72%
Axonics
Jan 16, 2024
Downgrades: Hold
Price Target: $73$71
Current: $70.24
Upside: +1.08%
SI-BONE
Dec 22, 2023
Maintains: Buy
Price Target: $25$26
Current: $12.27
Upside: +111.90%